DURECT Corporation (DRRX) by event type
DRRX moves most on rating reiterations — a median of -4.19% at 30 minutes across 16 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the DRRX overview →
How DRRX reacts across 3 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 1,285 of 2,603 | 12 | +0.01% | 58% | +3.76% |
| Coverage initiations 1,104 of 2,283 | 30 | 0.00% | 40% | -0.74% |
| Rating reiterations 3,522 of 3,522 | 16 | -4.19% | 25% | -2.92% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how DRRX usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Coverage initiations → · Rating reiterations → · DRRX overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AVITA MEDICAL (AVMXY) | 160 | 0.00% | 46% |
| Adaptimmune Therapeutics plc - American Depositary Shares (ADAP) | 159 | -1.17% | 27% |
| Galmed Pharmaceuticals Ltd. - Ordinary Shares (GLMD) | 159 | -1.80% | 36% |
| GT Biopharma, Inc. (GTBP) | 159 | -0.91% | 32% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.